Skip to content
You are now registered for this event

Permission Error

Something went wrong!

This educational event is organised and funded by GSK and is intended for Healthcare Professionals only.

Vaccine Virtual Days, 23 - 26 April, 2024 – Live & on demand

Join one of the world's largest global medical education events dedicated to adult immunisation.

Did you know?

"By 2030, 1 in 6 people in the world will be aged 60 years or over1. As populations age globally, we are seeing an increasing burden of vaccine-preventable disease in adults2".

Vaccine Virtual Days 2024 will be a contribution to the United Decade of Healthy Ageing, bringing together international health experts to discuss the challenges, opportunities and future of adult immunisation.

Register for this free medical education event to learn of the current trends, data and innovations surrounding the global adult immunisation community. The four-day event will span across three different time zones, covering the most pressing adult immunisation topics.

Day 1 Immunology and Age-Related Decline in Immunity, Importance of Adult Immunisation and United Nations Decade of Healthy Ageing

Day 2 – Respiratory Infectious Disease Prevention, Vaccines for Grown-Ups, Shared Clinical Decision Making Around Immunisation and Vaccine Equity

Day 3 – Patients at Increased Risk of Vaccine Preventable Disease and One Health

Day 4 – Patient Perspectives on the Path to Immunisation and Impact of Immunisation on Antimicrobial Resistance

Let science lead every day

Vaccine Virtual Days 2024 – Top line agenda

Please note that this agenda is subject to change

 

Date & Time

Session description

Day 1

CST April 23, 8.00 – 11.15pm

CEST April 23, 2.00 – 5.15pm

EDT April 23, 8.00 – 11.15am

  • Opening, Welcome, Introductions
  • A Year in Review: From Data to Clinical Practice – What Have We Learnt
  • Decade of Healthy Ageing – Where Are We and Where Are We Going?
  • Immunology and Age-Related Decline in Immunity: A Deep Dive
Day 2

CST April 25, 6.15 – 9.45am

CEST April 25, 12.15 – 3.45am

EDT April 24, 6.15 – 9.45pm

  • Latest Advances in Respiratory Infectious Disease Prevention
  • Proactive Prevention: Immunisation as a Pillar of Healthy Ageing
  • Vaccines for Grown-Ups: A Journey into Confidence, Equity, and the Power of Collaboration
Day 3

CST April 25, 12.00 – 2.55pm

CEST April 25, 6.00 – 8.55am

EDT April 25, 12.00 – 2.55am

  • The Value of Adult Immunisation
  • MY CONTRIBUTION to the Decade – Around the World in 5 Minutes
  • One Body, One Mind, One Health: A Life Course Approach to Managing Vaccine Preventable Diseases
Day 4

CST April 26, 8.00 – 11.00pm

CEST April 26, 2.00 – 5.00pm

EDT April 26, 8.00 – 11.00am

  • Prescribing Empathy: A Patient-Centric Prescription for Change
  • The Role of Vaccines in Addressing Antimicrobial Resistance
  • What Should We Look Out for in 2024/2025

Event will be going live from the bolded time zones

References

  1. World Health Organization 2022, Ageing and Health, accessed 1 October 2023, www.who.int/news-room/fact-sheets/detail/ageing-and-health
  2. Doherty TM et al. Adult vaccination as part of a healthy lifestyle: moving from medical intervention to health promotion. Ann Med. 2019 Mar;51(2):128-140.

All Healthcare Professionals are required to follow their country specific legal requirements and local guidelines for the reporting of adverse events.

Belgium: Please report adverse events to the Belgian Centre for Pharmacovigilance for medicines for Human use of the Federal Agency for Medicines and Health Products via adr@afmps.be or via www.notifieruneffetindesirable.be or to GlaxoSmithKline Pharmaceuticals s.a./n.v. via be.medinfo@gsk.com.

UK: Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on +44 (0) 800 221 441 or UKSafety@gsk.com.

Other countries: Please follow https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/

Privacy Notice | Terms of Use

© 2023 GSK group of companies or its licensor.

GlaxoSmithKline Biologicals SA, Rixensart, Belgium

NX-GBL-GVU-WCNT-230012 | January 2024